Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASCENDIS PHARMA A/S

(ASND)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-03 pm EST
116.10 USD   -1.39%
01/18Tech Stocks Lead European Equities Modestly Higher in Wednesday Trading
MT
01/17Pharma Stocks Lead European Equities Higher in Tuesday Trading
MT
01/17SVB Securities Adjusts Price Target on Ascendis Pharma to $163 From $148, Maintains Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Wednesday Trading

08/24/2022 | 11:04am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -4.05% 1.66 Delayed Quote.18.49%
AKARI THERAPEUTICS, PLC 4.62% 0.51 Delayed Quote.3.75%
ASCENDIS PHARMA A/S -1.39% 116.1 Delayed Quote.-4.94%
BRENT OIL -2.83% 79.73 Delayed Quote.-4.54%
CARNIVAL CORPORATION -1.99% 11.8 Delayed Quote.46.40%
CELLECTIS S.A. -20.67% 2.38 Real-time Quote.19.78%
CRH PLC 0.11% 3942 Delayed Quote.19.49%
ENI SPA 0.68% 13.844 Delayed Quote.4.20%
ERYTECH PHARMA S.A. 2.33% 1.14 Real-time Quote.210.80%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.42% 35.61 Delayed Quote.16.49%
FRESENIUS SE & CO. KGAA -0.44% 27.11 Delayed Quote.3.28%
MEREO BIOPHARMA GROUP PLC -0.86% 0.98 Delayed Quote.30.67%
MORPHOSYS AG -1.68% 19 Delayed Quote.43.83%
NUCANA PLC 3.23% 1.6 Delayed Quote.142.42%
PRUDENTIAL PLC 0.59% 1354 Delayed Quote.20.09%
SEQUANS COMMUNICATIONS S.A. 0.62% 3.24 Delayed Quote.-3.01%
TOTALENERGIES SE 2.12% 56.35 Real-time Quote.-3.92%
VERONA PHARMA PLC 3.37% 21.19 Delayed Quote.-21.55%
WTI 0.00% 73.419 Delayed Quote.-5.67%
All news about ASCENDIS PHARMA A/S
01/18Tech Stocks Lead European Equities Modestly Higher in Wednesday Trading
MT
01/17Pharma Stocks Lead European Equities Higher in Tuesday Trading
MT
01/17SVB Securities Adjusts Price Target on Ascendis Pharma to $163 From $148, Maintains Out..
MT
01/10BioAtla Sees Dosing of First Patient in Mid-Stage Part 2 Study in Soft Tissue Cancer Th..
MT
01/09Transcript : Ascendis Pharma A/S Presents at 41st Annual J.P. Morgan Healthca..
CI
01/09European Equities Begin Week With Sharp Rise
MT
01/09Ascendis Pharma A/s : INCORPORATION BY REFERENCE - Form 6-K
PU
01/08Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Mor..
AQ
01/04Online Enrollment Now Open for Physicians Requesting Expanded Access to Ascendis Pharma..
AQ
01/03Ascendis Pharma A/s : Articles of Association - Form 6-K
PU
More news
Analyst Recommendations on ASCENDIS PHARMA A/S
More recommendations
Financials
Sales 2022 45,8 M 49,7 M 49,7 M
Net income 2022 -530 M -575 M -575 M
Net cash 2022 455 M 494 M 494 M
P/E ratio 2022 -11,2x
Yield 2022 -
Capitalization 5 991 M 6 501 M 6 501 M
EV / Sales 2022 121x
EV / Sales 2023 41,1x
Nbr of Employees 639
Free-Float 10,3%
Chart ASCENDIS PHARMA A/S
Duration : Period :
Ascendis Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASCENDIS PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 106,99 €
Average target price 146,94 €
Spread / Average Target 37,3%
EPS Revisions
Managers and Directors
Jan M°ller Mikkelsen President, CEO & Executive Director
Scott Thomas Smith Chief Financial Officer & Senior Vice President
Albert Cha Chairman
Birgitte Volck SVP, Head-Clinical Development & Medical Affairs
Kennett Sprog°e Senior Vice President, Head-Innovation & Research
Sector and Competitors
1st jan.Capi. (M$)
ASCENDIS PHARMA A/S-4.94%6 501
REGENERON PHARMACEUTICALS, INC.4.12%80 230
VERTEX PHARMACEUTICALS5.19%77 978
WUXI APPTEC CO., LTD.15.80%41 417
BIONTECH SE-3.87%35 092
BEIGENE, LTD.15.96%26 559